Further in vitro biological activity evaluation of amino-, thio-and ester-derivatives of avarol

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The acetylcholinesterase inhibitory and/or antitumour activities of amino-, thio-and ester-derivatives of avarol selected were evaluated for the first time at in vitro conditions. Avarol-3′,4′-dithioglycol (1) and avarol-4′-(3)mercaptopropionic acid (3) were shown to be the best inhibitors of the enzyme tested (0.50g and IC50 0.05mM and 0.50g and IC50 0.12mM, respectively), while 4′-tryptamine-avarone (9) and avarol-3′-(3)mercaptopropionic acid (2) exhibited the highest cytotoxicity against the human breast T-47D cancer cell line (IC50 0.66g/mL and 1.25g/mL, respectively). According to experimental data obtained, the sesquiterpenoid hydroquinone structure of bioactive avarol derivatives may inspire development of new pharmacologically useful substances to be used in the treatment of Alzheimer's disease and/or human breast tumour.

Cite

CITATION STYLE

APA

Tommonaro, G., Pejin, B., Iodice, C., Tafuto, A., & De Rosa, S. (2015). Further in vitro biological activity evaluation of amino-, thio-and ester-derivatives of avarol. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(2), 333–335. https://doi.org/10.3109/14756366.2014.913037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free